Abbvie (ABBV) — capital discipline, read against the 10-Q

Abbviereason 04 of 4a reason to hold, not a barrierderived 2026-09-11accession 0001551152-26-000026

Cash flows from operations of $7.3 billion for the six months ended June 30, 2026

Financing cash flows included cash dividend payments of $6.2 billion for the six months ended June 30, 2026

On June 18, 2026, the company announced that its board of directors declared a quarterly dividend of $1.73 per share

In June 2026, Standard and Poor's Global Ratings affirmed AbbVie's senior unsecured long-term credit rating of A- and revised AbbVie's outlook to positive from stable

the finding

The disclosure updates from the February declaration to a June declaration of the same $1.73 quarterly dividend, consistent with the stated dividend reason but not itself stating a change in dividend policy or amount.

The report says this changed. It does not say whether that is good or bad, so neither do we.

before · MD&A · 2026-03-31 → 2026-06-30

“On February 19, 2026, the company announced that its board of directors declared a quarterly dividend of $1.73 per share beginning with the dividend payable on May 15, 2026”